世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

【PT:変革の地平レポート】企業のウェアラブル:半期毎の市場概要

Enterprise Wearables Bi-Annual Review

3Q 2017 | Transformative Horizon Report | PT-1787 | 18 pages | PDF | Powerpoint |

 

出版社 出版年月価格 ページ数
ABI Research
ABIリサーチ
2017年9月お問い合わせください 18

サマリー

The 3Q 2017 enterprise wearable market update provides an overview of current enterprise wearable developments, announcements, forecasts, latest research, and recommendations for enterprise wearable suppliers and enterprise end users. Slides include: market developments, forecast findings, opportunities, threats, and guidance. Forecasts include Enterprise Wearable Shipments by Device Type and Enterprise Wearable Shipments by Vertical.

 

ABIリサーチの調査レポートの詳細については、サンプルをご請求ください。

(株式会社データリソース 03-3582-2531、office@dri.co.jp)

 



目次

  • Market Developments
  • Key Forecast Findings
  • Opportunities
  • Disruptive Threats
  • Guidance for Manufacturers and Suppliers
  • Guidance for Enterprise End Users
  • Author and Contact Information

 

ページTOPに戻る

プレスリリース

[プレスリリース原文]

Enterprise Wearables Forecasted to Reach 118 Million Shipments in 2022
 
London, United Kingdom - 27 Sep 2017

ABI Research forecasts that enterprise wearable shipments will reach over 118 million in 2022, increasing from just over 38 million in 2017, a CAGR of 25%. The enterprise wearables market is continuing to see stronger growth than the consumer market, which has shipment numbers increasing at a lower CAGR of 13%.   Healthcare devices, wearable cameras, and wearable scanners will account for 73% of enterprise wearable shipments in 2022. Innovative companies are leading the charge, such as Royole with flexible components, Waverly with real-time translation, and Axon (previously Taser) with wearable cameras.

“Despite currently having lower shipment numbers, enterprise wearables are growing at a much stronger rate than consumer devices,” says Stephanie Lawrence, Research Analyst at ABI Research. “These devices provide users across all industry verticals with hands-free access to information and communication, enabling them to become more productive.”

Healthcare devices are the dominant enterprise wearable device type due to the significant benefits that they provide within the healthcare industry, such as the ability to remotely monitor many patients’ vitals at one time. The devices account for 30% of enterprise wearable device shipments, as the healthcare industry vertical requires a large number of the devices for the continuously growing number of patients.

Wearable cameras and scanners are other dominant device types, Wearable cameras are particularly strong in the government and military industry vertical which accounts for 26% of the device shipments. This is mostly due to the devices’ ability to record information (for example, police officer activity), which can then be used as indisputable evidence. Wearable scanners account for 37% of the shipments. Wearable scanners aid workers, particularly those in warehouses and manufacturing, granting the ability to scan barcodes while they work and improving productivity as they do not have to pick up and put down a separate device.

“Enterprise wearable device usage is continuously on the rise because more and more companies are understanding the benefits of deploying the devices to specific tasked workers,” concludes Lawrence. “Return on Investment potential is continually shown, and key performance indicators are proving positive. This will continue to cause enterprise wearable shipments to rise at a higher rate than consumer wearable shipments, where the devices productivity improvement benefits do not have don’t have the same impact.”

These findings are from ABI Research’s Enterprise Wearables Biannual Review report. These reports are part of the company’s Wearables, Usables, and Expendables research service, which includes research, data, and analyst insights.

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る